Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels.

Ratte, Antonius; Wiedmann, Felix; Kraft, Manuel; Katus, Hugo A; Schmidt, Constanze

Ratte, Antonius; Wiedmann, Felix; Kraft, Manuel; Katus, Hugo A; Schmidt, Constanze.

Afiliación

Ratte A; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
Wiedmann F; DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany.
Kraft M; HCR, Heidelberg Centre for Heart Rhythm Disorders, University of Heidelberg, Heidelberg, Germany.
Katus HA; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
Schmidt C; DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany.

Front Pharmacol ; 10: 1367, 2019.

Article en En | MEDLINE | ID: mdl-32038227

Palabras clave

K2P3.1; KCNK3; TASK-1; antiarrhythmic drugs; atrial fibrillation; ranolazine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google